Stephan Grupp Md Phd
Clinical trials sponsored by Stephan Grupp Md Phd, explained in plain language.
-
New hope for kids with tough leukemia: smarter CAR T-Cell production under study
Disease control Recruiting nowThis study is for children with B-cell acute lymphoblastic leukemia (B-ALL) that has come back or not responded to treatment. Researchers are testing a new way to make special immune cells, called CAR T-cells, using a machine called CliniMACS Prodigy. The goal is to see if this n…
Phase: PHASE1, PHASE2 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
Engineered immune cells take on childhood cancers in first human trial
Disease control Recruiting nowThis early-phase trial tests a new treatment called GPC2 CAR T cells for children with advanced neuroblastoma or retinoblastoma that has come back or not responded to standard therapy. The treatment uses the patient's own immune cells, modified to target a protein (GPC2) on cance…
Phase: PHASE1 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
New cell therapy offers hope for kids with rare leukemia
Disease control Recruiting nowThis study tests a treatment called CART19, which uses a patient's own immune cells modified to attack leukemia cells. It is for children and young adults with certain high-risk types of B-cell acute lymphoblastic leukemia (B-ALL) that are hard to treat. The goal is to see if thi…
Phase: PHASE2 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC